• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

优化用于组织工程的支架孔径:对各种组织类型的见解

Optimizing scaffold pore size for tissue engineering: insights across various tissue types.

作者信息

Mukasheva Fariza, Adilova Laura, Dyussenbinov Aibek, Yernaimanova Bota, Abilev Madi, Akilbekova Dana

机构信息

Department of Chemical and Materials Engineering, School of Engineering and Digital Sciences, Nazarbayev University, Astana, Kazakhstan.

Department of Analytical, Colloid Chemistry and Technology of Rare Elements, Al-Farabi Kazakh National University, Almaty, Kazakhstan.

出版信息

Front Bioeng Biotechnol. 2024 Nov 12;12:1444986. doi: 10.3389/fbioe.2024.1444986. eCollection 2024.

DOI:10.3389/fbioe.2024.1444986
PMID:39600888
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11588461/
Abstract

Scaffold porosity is a critical factor in replicating the complex microenvironment, directly influencing cellular interactions, migration, nutrient transfer, vascularization, and the formation of functional tissues. For optimal tissue formation, scaffold design must account for various parameters, including material composition, morphology, mechanical properties, and cellular compatibility. This review highlights the importance of interconnected porosity and pore size, emphasizing their impact on cellular behavior and tissue formation across several tissue engineering domains, such as skin, bone, cardiovascular, and lung tissues. Specific pore size ranges enhance scaffold functionality for different tissues: small pores (∼1-2 µm) aid epidermal cell attachment in skin regeneration, moderate pores (∼2-12 µm) support dermal migration, and larger pores (∼40-100 µm) facilitate vascular structures. For bone tissue engineering, multi-layered scaffolds with smaller pores (50-100 µm) foster cell attachment, while larger pores (200-400 µm) enhance nutrient diffusion and angiogenesis. Cardiovascular and lung tissues benefit from moderate pore sizes (∼25-60 µm) to balance cell integration and nutrient diffusion. By addressing critical design challenges and optimizing pore size distributions, this review provides insights into scaffold innovations, ultimately advancing tissue regeneration strategies.

摘要

支架孔隙率是复制复杂微环境的关键因素,直接影响细胞相互作用、迁移、营养物质传递、血管化以及功能组织的形成。为实现最佳的组织形成,支架设计必须考虑各种参数,包括材料组成、形态、力学性能和细胞相容性。本综述强调了相互连通的孔隙率和孔径的重要性,着重阐述了它们在多个组织工程领域(如皮肤、骨骼、心血管和肺组织)对细胞行为和组织形成的影响。特定的孔径范围可增强不同组织的支架功能:小孔径(约1-2微米)有助于皮肤再生中表皮细胞的附着,中等孔径(约2-12微米)支持真皮迁移,而较大孔径(约40-100微米)则有利于血管结构的形成。对于骨组织工程,具有较小孔径(50-100微米)的多层支架可促进细胞附着,而较大孔径(200-400微米)则可增强营养物质扩散和血管生成。心血管和肺组织受益于中等孔径(约25-60微米),以平衡细胞整合和营养物质扩散。通过应对关键的设计挑战并优化孔径分布,本综述为支架创新提供了见解,最终推动组织再生策略的发展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c81/11588461/1b042d38ab85/fbioe-12-1444986-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c81/11588461/a9dabe587c3f/fbioe-12-1444986-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c81/11588461/208e74b758b9/fbioe-12-1444986-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c81/11588461/2d4ca5e94412/fbioe-12-1444986-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c81/11588461/1b042d38ab85/fbioe-12-1444986-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c81/11588461/a9dabe587c3f/fbioe-12-1444986-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c81/11588461/208e74b758b9/fbioe-12-1444986-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c81/11588461/2d4ca5e94412/fbioe-12-1444986-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c81/11588461/1b042d38ab85/fbioe-12-1444986-g004.jpg

相似文献

1
Optimizing scaffold pore size for tissue engineering: insights across various tissue types.优化用于组织工程的支架孔径:对各种组织类型的见解
Front Bioeng Biotechnol. 2024 Nov 12;12:1444986. doi: 10.3389/fbioe.2024.1444986. eCollection 2024.
2
The pore size of polycaprolactone scaffolds has limited influence on bone regeneration in an in vivo model.聚己内酯支架的孔径大小对体内模型中的骨再生的影响有限。
J Biomed Mater Res A. 2010 Jan;92(1):359-68. doi: 10.1002/jbm.a.32381.
3
Porosity of 3D biomaterial scaffolds and osteogenesis.3D生物材料支架的孔隙率与骨生成
Biomaterials. 2005 Sep;26(27):5474-91. doi: 10.1016/j.biomaterials.2005.02.002.
4
Scaffold Pore Curvature Influences ΜSC Fate through Differential Cellular Organization and YAP/TAZ Activity.支架孔曲率通过细胞的不同组织和 YAP/TAZ 活性影响间充质干细胞命运。
Int J Mol Sci. 2022 Apr 19;23(9):4499. doi: 10.3390/ijms23094499.
5
Bioceramic hydroxyapatite-based scaffold with a porous structure using honeycomb as a natural polymeric Porogen for bone tissue engineering.基于生物陶瓷羟基磷灰石的支架,具有多孔结构,使用蜂窝作为天然聚合物致孔剂用于骨组织工程。
Biomater Res. 2021 Jan 19;25(1):2. doi: 10.1186/s40824-021-00203-z.
6
Scaffold pore size modulates in vitro osteogenesis of human adipose-derived stem/stromal cells.支架孔径调节人脂肪来源的干/基质细胞的体外成骨作用。
Biomed Mater. 2014 Aug;9(4):045003. doi: 10.1088/1748-6041/9/4/045003. Epub 2014 Jun 19.
7
The effect of mean pore size on cell attachment, proliferation and migration in collagen-glycosaminoglycan scaffolds for bone tissue engineering.平均孔径对用于骨组织工程的胶原糖胺聚糖支架中细胞黏附、增殖和迁移的影响。
Biomaterials. 2010 Jan;31(3):461-6. doi: 10.1016/j.biomaterials.2009.09.063. Epub 2009 Oct 9.
8
Pore size directs bone marrow stromal cell fate and tissue regeneration in nanofibrous macroporous scaffolds by mediating vascularization.孔径大小通过调节血管生成来指导纳米纤维大孔支架中的骨髓基质细胞命运和组织再生。
Acta Biomater. 2018 Dec;82:1-11. doi: 10.1016/j.actbio.2018.10.016. Epub 2018 Oct 13.
9
Novel-Ink-Based Direct Ink Writing of Ti6Al4V Scaffolds with Sub-300 µm Structural Pores for Superior Cell Proliferation and Differentiation.基于新型油墨的 Ti6Al4V 支架的直接喷墨打印,具有小于 300μm 的亚结构孔,可实现优异的细胞增殖和分化。
Adv Healthc Mater. 2024 Apr;13(10):e2302396. doi: 10.1002/adhm.202302396. Epub 2024 Jan 14.
10
In vitro and in vivo characteristics of PCL scaffolds with pore size gradient fabricated by a centrifugation method.通过离心法制备的具有孔径梯度的聚己内酯支架的体外和体内特性
Biomaterials. 2007 Mar;28(9):1664-71. doi: 10.1016/j.biomaterials.2006.11.024. Epub 2006 Dec 28.

引用本文的文献

1
Synergistic Angio-Osteogenic Effects of Copper-Releasing 3D Biocomposite Scaffolds: A Step Toward Vascularized Bone Regeneration.释放铜的3D生物复合支架的协同血管生成和成骨作用:迈向血管化骨再生的一步。
Res Sq. 2025 Aug 26:rs.3.rs-7159849. doi: 10.21203/rs.3.rs-7159849/v1.
2
New Frontiers in 3D Printing Using Biocompatible Polymers.使用生物相容性聚合物的3D打印新前沿
Int J Mol Sci. 2025 Aug 19;26(16):8016. doi: 10.3390/ijms26168016.
3
Preliminary Preclinical Evaluation of Innovative Bone Scaffolds Composed of Natural Sources-Whey Protein Isolate and Pearl Powder.
由天然来源——乳清分离蛋白和珍珠粉组成的创新型骨支架的临床前初步评估
Int J Mol Sci. 2025 Aug 17;26(16):7939. doi: 10.3390/ijms26167939.
4
Healing Kinetics of Sinus Lift Augmentation Using Biphasic Calcium Phosphate Granules: A Case Series in Humans.使用双相磷酸钙颗粒进行上颌窦提升术的愈合动力学:人类病例系列
Bioengineering (Basel). 2025 Aug 6;12(8):848. doi: 10.3390/bioengineering12080848.
5
Hybrid Chitosan/PCL Shape Memory Scaffolds with Potential for Bone Regeneration and Infection Resistance.具有骨再生和抗感染潜力的壳聚糖/聚己内酯混合形状记忆支架
ACS Biomater Sci Eng. 2025 Sep 8;11(9):5627-5637. doi: 10.1021/acsbiomaterials.5c01160. Epub 2025 Aug 21.
6
Novel Nanomaterials for Developing Bone Scaffolds and Tissue Regeneration.用于开发骨支架和组织再生的新型纳米材料。
Nanomaterials (Basel). 2025 Aug 5;15(15):1198. doi: 10.3390/nano15151198.
7
Biodegradable Polyesters: Approaches to Increase Degradation Rates for Biomedical Applications.可生物降解聚酯:提高生物医学应用降解速率的方法
ACS Macro Lett. 2025 Aug 19;14(8):1221-1240. doi: 10.1021/acsmacrolett.5c00417. Epub 2025 Aug 10.
8
Tissue Engineering In Vitro Leaflet- and 3-Dimensional Printing-Based Implant Prototypes for Infant Mitral Valve.用于婴儿二尖瓣的基于组织工程体外小叶和三维打印的植入物原型
BME Front. 2025 Aug 7;6:0159. doi: 10.34133/bmef.0159. eCollection 2025.
9
Influence of Scaffold Structure and Biomimetic Properties on Adipose Stem Cell Homing in Personalized Reconstructive Medicine.支架结构和仿生特性对个性化重建医学中脂肪干细胞归巢的影响。
Biomimetics (Basel). 2025 Jul 3;10(7):438. doi: 10.3390/biomimetics10070438.
10
Bioprinting for drug screening: A path toward reducing animal testing or redefining preclinical research?用于药物筛选的生物打印:是减少动物实验的途径还是重新定义临床前研究?
Bioact Mater. 2025 Jul 15;51:993-1017. doi: 10.1016/j.bioactmat.2025.07.006. eCollection 2025 Sep.